CLYM (Climb Bio) Short Ratio


CLYM Climb Bio Inc CLYM
22 GF Score
Price $14.00
! 3 Warning Signs
View Full Analysis

What is Climb Bio Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

CLYM
22GF Score
Climb Bio Inc CLYM
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Climb Bio Business Description

Address 20 William Street, Suite 145, Wellesley Hills, MA, USA, 02481
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.
22GF Score

Get the complete analysis for CLYM

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.00
Price